> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guidance on Drugs for Treating Herpes
- URL: https://www.fdaweb.com/guidance-on-drugs-for-treating-herpes/
- Published: 2016-07-01T12:00:00.000Z
- Updated: 2026-09-14T21:13:03.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136106

*Federal Register* Notice: FDA is making available a draft guidance for industry entitled *Recurrent Herpes Labialis: Developing Drugs for Treatment and Prevention*. Its purpose is to assist sponsors in all phases of development of treatments for recurrent herpes labialis. The guidance also addresses preventing recurrent herpes labialis and outlines the types of nonclinical studies and clinical trials recommended throughout the drug development process to support approval of antiviral drug products for the treatment or prevention of recurrent herpes labialis. To download this guidance, click [here](http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM509410?ref=fdaweb.com). To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-07-01/pdf/2016-15698.pdf?ref=fdaweb.com)